These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15115610)

  • 1. Myosin binding protein C: structural abnormalities in familial hypertrophic cardiomyopathy.
    Oakley CE; Hambly BD; Curmi PM; Brown LJ
    Cell Res; 2004 Apr; 14(2):95-110. PubMed ID: 15115610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myosin binding protein-C: enigmatic regulator of cardiac contraction.
    Oakley CE; Chamoun J; Brown LJ; Hambly BD
    Int J Biochem Cell Biol; 2007; 39(12):2161-6. PubMed ID: 17320463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes.
    Flavigny J; Souchet M; Sébillon P; Berrebi-Bertrand I; Hainque B; Mallet A; Bril A; Schwartz K; Carrier L
    J Mol Biol; 1999 Nov; 294(2):443-56. PubMed ID: 10610770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in beta-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosin-binding protein-C.
    Gruen M; Gautel M
    J Mol Biol; 1999 Feb; 286(3):933-49. PubMed ID: 10024460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional and spectroscopic studies of a familial hypertrophic cardiomyopathy mutation in Motif X of cardiac myosin binding protein-C.
    Brown LJ; Singh L; Sale KL; Yu B; Trent R; Fajer PG; Hambly BD
    Eur Biophys J; 2002 Sep; 31(5):400-8. PubMed ID: 12202917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac myosin binding protein C: its role in physiology and disease.
    Flashman E; Redwood C; Moolman-Smook J; Watkins H
    Circ Res; 2004 May; 94(10):1279-89. PubMed ID: 15166115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy.
    Carrier L; Bonne G; Bährend E; Yu B; Richard P; Niel F; Hainque B; Cruaud C; Gary F; Labeit S; Bouhour JB; Dubourg O; Desnos M; Hagège AA; Trent RJ; Komajda M; Fiszman M; Schwartz K
    Circ Res; 1997 Mar; 80(3):427-34. PubMed ID: 9048664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional studies of titin's fn3 modules reveal conserved surface patterns and binding to myosin S1--a possible role in the Frank-Starling mechanism of the heart.
    Muhle-Goll C; Habeck M; Cazorla O; Nilges M; Labeit S; Granzier H
    J Mol Biol; 2001 Oct; 313(2):431-47. PubMed ID: 11800567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cardiac myosin binding protein C mutation in the Maine Coon cat with familial hypertrophic cardiomyopathy.
    Meurs KM; Sanchez X; David RM; Bowles NE; Towbin JA; Reiser PJ; Kittleson JA; Munro MJ; Dryburgh K; Macdonald KA; Kittleson MD
    Hum Mol Genet; 2005 Dec; 14(23):3587-93. PubMed ID: 16236761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cardiac myosin-binding protein-C (cMyBP-C) in Drosophila as a model for the study of human cardiomyopathies.
    Vu Manh TP; Mokrane M; Georgenthum E; Flavigny J; Carrier L; Sémériva M; Piovant M; Röder L
    Hum Mol Genet; 2005 Jan; 14(1):7-17. PubMed ID: 15525659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and phenotypic characterization of mutations in myosin-binding protein C (MYBPC3) in 81 families with familial hypertrophic cardiomyopathy: total or partial haploinsufficiency.
    Andersen PS; Havndrup O; Bundgaard H; Larsen LA; Vuust J; Pedersen AK; Kjeldsen K; Christiansen M
    Eur J Hum Genet; 2004 Aug; 12(8):673-7. PubMed ID: 15114369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic screening of calcium regulation genes in familial hypertrophic cardiomyopathy.
    Chiu C; Tebo M; Ingles J; Yeates L; Arthur JW; Lind JM; Semsarian C
    J Mol Cell Cardiol; 2007 Sep; 43(3):337-43. PubMed ID: 17655857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetics of familial hypertrophic cardiomyopathy (FHC).
    Bashyam MD; Savithri GR; Kumar MS; Narasimhan C; Nallari P
    J Hum Genet; 2003; 48(2):55-64. PubMed ID: 12601548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A frameshift deletion mutation in the cardiac myosin-binding protein C gene associated with dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy.
    Hitomi N; Kubo T; Kitaoka H; Hirota T; Hamada T; Hoshikawa E; Hayato K; Okawa M; Kimura A; Doi YL
    J Cardiol; 2010 Sep; 56(2):189-96. PubMed ID: 20605413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation and mutation of human cardiac troponin I deferentially destabilize the interaction of the functional regions of troponin I with troponin C.
    Li MX; Wang X; Lindhout DA; Buscemi N; Van Eyk JE; Sykes BD
    Biochemistry; 2003 Dec; 42(49):14460-8. PubMed ID: 14661957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic deficits in mice expressing a myosin binding protein C lacking the titin and myosin binding domains.
    Yang Q; Osinska H; Klevitsky R; Robbins J
    J Mol Cell Cardiol; 2001 Sep; 33(9):1649-58. PubMed ID: 11549344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of the binding site of the C-terminal domain of cardiac myosin-binding protein-C on the myosin rod.
    Flashman E; Watkins H; Redwood C
    Biochem J; 2007 Jan; 401(1):97-102. PubMed ID: 16918501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice.
    McConnell BK; Jones KA; Fatkin D; Arroyo LH; Lee RT; Aristizabal O; Turnbull DH; Georgakopoulos D; Kass D; Bond M; Niimura H; Schoen FJ; Conner D; Fischman DA; Seidman CE; Seidman JG
    J Clin Invest; 1999 Nov; 104(9):1235-44. PubMed ID: 10545522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human homozygous R403W mutant cardiac myosin presents disproportionate enhancement of mechanical and enzymatic properties.
    Keller DI; Coirault C; Rau T; Cheav T; Weyand M; Amann K; Lecarpentier Y; Richard P; Eschenhagen T; Carrier L
    J Mol Cell Cardiol; 2004 Mar; 36(3):355-62. PubMed ID: 15010274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do the FHC-associated R403 mutations in myosin heavy chain lead to a greater energetic cost of contraction?
    Ingwall JS
    J Mol Cell Cardiol; 2004 Mar; 36(3):327-30. PubMed ID: 15010270
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.